Nanogel-crosslinked nanoparticles increase the inhibitory effects of W9 synthetic peptide on bone loss in a murine bone resorption model

We investigated the biological activity of W9, a bone resorption inhibitor peptide, using NanoClik nanoparticles as an injectable carrier, where acryloyl group-modified cholesterol-bearing pullulan (CHPOA) nanogels were crosslinked by pentaerythritol tetra (mercaptoethyl) polyoxyethylene. Thirty 5-w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Toshimi, Alles, Neil, Khan, Masud, Nagano, Kenichi, Takahashi, Mariko, Tamura, Yukihiko, Shimoda, Asako, Ohya, Keiichi, Akiyoshi, Kazunari, Aoki, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435441/
https://www.ncbi.nlm.nih.gov/pubmed/25999711
http://dx.doi.org/10.2147/IJN.S61566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435441/
https://www.ncbi.nlm.nih.gov/pubmed/25999711
http://dx.doi.org/10.2147/IJN.S61566

Ejemplares similares